Two Sigma Securities’s Vyant Bio VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-4,307
Closed -$12K – 3458
2022
Q3
$12K Buy
+4,307
New +$16.3K ﹤0.01% 2384
2019
Q4
– Sell
-248
Closed -$4K – 2727
2019
Q3
$4K Sell
248
-34
-12% -$662 ﹤0.01% 2012
2019
Q2
$7K Buy
+282
New +$8.8K ﹤0.01% 2015
2019
Q1
– Sell
-128
Closed -$5K – 2583
2018
Q4
$5K Sell
128
-28
-18% -$2.36K ﹤0.01% 2059
2018
Q3
$24K Buy
+156
New +$23.1K ﹤0.01% 2421
2018
Q1
– Sell
-451
Closed -$125K – 3039
2017
Q4
$125K Buy
451
+354
+365% +$135K ﹤0.01% 1425
2017
Q3
$39K Buy
+97
New +$50.6K ﹤0.01% 766
2017
Q2
– Sell
-107
Closed -$66K – 1243
2017
Q1
$66K Buy
+107
New +$38.1K 0.01% 781

Other funds holding VYNT

Two Sigma Securities's VYNT Position: Q4 2022 in Review

Two Sigma Securities sold out of Vyant Bio (VYNT) in Q4 2022, closing a stake of 4,307 shares — an estimated $12K sold.

Two Sigma Securities first reported a position in VYNT in Q1 2017 and held it in 8 quarters. The position peaked at $125K in Q4 2017. 17 funds tracked by Wall St. Rank hold VYNT as of Q4 2022.

  • Two Sigma Securities reported no remaining Vyant Bio position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 4,307 Vyant Bio shares in Q4 2022, an estimated $12K.
  • Two Sigma Securities first reported a position in Vyant Bio in Q1 2017 and held it in 8 quarters.
  • Two Sigma Securities's Vyant Bio position peaked at $125K in Q4 2017.
  • 17 funds tracked by Wall St. Rank held Vyant Bio as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.